NCT02272270View on ClinicalTrials.gov

Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 27, 2014

Primary Completion Date

March 8, 2017

Study Completion Date

February 18, 2018

Conditions
Newly Diagnosed High Grade Glioma
Interventions
DRUG

Minocycline with chemoradiation (temozolomide and radiation therapy)

Patients receive minocycline in conjunction with standard chemoradiation and then they receive minocycline with standard chemotherapy.

Trial Locations (1)

84112

Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT02272270 - Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED) | Biotech Hunter | Biotech Hunter